Angiosarcoma — Trials

Angiosarcoma — Trials · CancerIndex

Clinical trials

Registered studies

53 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 16
Recruiting: 10
Ph III recruiting: 0
Growth YoY: —
Industry share: 19%
Top sponsor: Memorial Sloan Kettering Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (8)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05026736	Sintilimab for the Treatment of Locally Advanced, Metastatic, or Recurrent Angiosarcoma, the SiARa Cancer Study	terminated	Phase 2	6	M.D. Anderson Cancer CenterOTHER	1	Jul 21, 2026	clinicaltrials
NCT03921073	Study of T-VEC in Locally Advanced Cutaneous Angiosarcoma	terminated	Phase 2	5	H. Lee Moffitt Cancer Center and Research InstituteOTHER	1	Nov 1, 2022	clinicaltrials